PortfoliosLab logoPortfoliosLab logo
22526-2
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GDX 23.93%SIVR 6.18%1 position 2.22%RDIV 48.11%VOO 9.82%16 positions 6.73%1 position 2.87%AlternativesAlternativesCommodityCommodityEquityEquityMulti-AssetMulti-Asset

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in 22526-2, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Feb 22, 2024, corresponding to the inception date of MSTY

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-4.18%-3.84%-1.98%21.98%16.86%10.37%12.29%
Portfolio
22526-2
-0.60%-4.93%6.91%14.58%50.97%
ALKS
Alkermes plc
-0.60%18.99%24.52%12.17%10.04%6.71%12.72%-0.42%
CMPS
COMPASS Pathways plc
3.02%-17.87%-16.09%-9.95%104.59%-16.37%-31.18%
DFTX
Definium Therapeutics, Inc
0.39%16.44%54.44%64.65%272.61%89.27%
ENVB
Enveric Biosciences Inc
-5.14%-2.87%-44.08%-75.57%-86.78%-80.82%-85.16%-73.61%
MLI
Mueller Industries, Inc.
-1.61%-6.44%-3.25%10.76%51.14%45.85%41.13%25.19%
VYGR
Voyager Therapeutics, Inc.
-0.75%-4.12%0.76%-18.52%27.33%-21.29%-3.97%-7.79%
FMED
Fidelity Disruptive Medicine ETF
-0.07%-4.82%-8.79%-4.06%7.50%
FRNW
Fidelity Clean Energy ETF
-0.95%2.43%13.27%12.48%80.11%2.42%
GDX
VanEck Gold Miners ETF
-1.48%-10.66%10.28%23.61%108.39%43.61%24.72%18.24%
IBBQ
Invesco Nasdaq Biotechnology ETF
-0.44%-1.95%2.54%15.49%42.63%12.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 23, 2024, 22526-2's average daily return is +0.13%, while the average monthly return is +2.59%. At this rate, your investment would double in approximately 2.3 years.

Historically, 78% of months were positive and 22% were negative. The best month was Aug 2025 with a return of +10.3%, while the worst month was Mar 2026 at -8.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 1 months.

On a daily basis, 22526-2 closed higher 60% of trading days. The best single day was Apr 9, 2025 with a return of +7.1%, while the worst single day was Apr 4, 2025 at -6.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.76%8.47%-8.06%0.42%6.91%
20255.99%1.54%3.00%-1.81%3.09%3.29%0.72%10.33%8.15%-0.72%6.38%2.43%50.70%
20240.71%9.38%-1.21%6.11%-1.99%7.40%2.48%1.94%0.52%1.50%-6.77%20.79%

Benchmark Metrics

22526-2 has an annualized alpha of 27.00%, beta of 0.69, and R² of 0.39 versus S&P 500 Index. Calculated based on daily prices since February 23, 2024.

  • This portfolio captured 156.93% of S&P 500 Index gains but only 14.98% of its losses — a favorable profile for investors.
  • Beta of 0.69 may look defensive, but with R² of 0.39 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R² of 0.39 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
27.00%
Beta
0.69
0.39
Upside Capture
156.93%
Downside Capture
14.98%

Expense Ratio

22526-2 has an expense ratio of 0.38%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Top 10 holdings

Return for Risk

Risk / Return Rank

22526-2 ranks 88 for risk / return — in the top 88% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


22526-2 Risk / Return Rank: 8888
Overall Rank
22526-2 Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
22526-2 Sortino Ratio Rank: 8888
Sortino Ratio Rank
22526-2 Omega Ratio Rank: 9090
Omega Ratio Rank
22526-2 Calmar Ratio Rank: 8686
Calmar Ratio Rank
22526-2 Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.18

0.88

+1.30

Sortino ratio

Return per unit of downside risk

2.68

1.37

+1.32

Omega ratio

Gain probability vs. loss probability

1.41

1.21

+0.20

Calmar ratio

Return relative to maximum drawdown

3.49

1.39

+2.10

Martin ratio

Return relative to average drawdown

13.43

6.43

+6.99


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ALKS
Alkermes plc
440.170.541.070.320.58
CMPS
COMPASS Pathways plc
750.951.691.262.116.77
DFTX
Definium Therapeutics, Inc
973.733.711.4411.0232.88
ENVB
Enveric Biosciences Inc
7-0.66-1.380.82-0.97-1.58
MLI
Mueller Industries, Inc.
761.371.851.271.995.64
VYGR
Voyager Therapeutics, Inc.
500.230.891.100.470.98
FMED
Fidelity Disruptive Medicine ETF
160.220.481.060.361.09
FRNW
Fidelity Clean Energy ETF
962.903.531.456.8920.22
GDX
VanEck Gold Miners ETF
892.352.551.373.5012.47
IBBQ
Invesco Nasdaq Biotechnology ETF
851.742.361.303.8914.37

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

22526-2 Sharpe ratios as of Apr 4, 2026 (values are recalculated daily):

  • 1-Year: 2.18
  • All Time: 2.12

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.99 to 1.69, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of 22526-2 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

22526-2 provided a 2.80% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio2.80%2.93%2.90%2.63%2.35%2.44%2.90%2.35%2.52%2.57%1.43%2.67%
ALKS
Alkermes plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CMPS
COMPASS Pathways plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ENVB
Enveric Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MLI
Mueller Industries, Inc.
0.99%0.87%1.01%1.27%1.69%0.88%1.14%1.26%1.71%9.60%0.94%1.11%
VYGR
Voyager Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FRNW
Fidelity Clean Energy ETF
1.11%1.25%1.43%1.30%0.69%0.04%0.00%0.00%0.00%0.00%0.00%0.00%
GDX
VanEck Gold Miners ETF
0.67%0.74%1.19%1.61%1.66%1.67%0.53%0.67%0.50%0.76%0.26%0.85%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.86%0.90%1.14%0.81%0.76%0.63%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the 22526-2. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 22526-2 was 13.09%, occurring on Mar 20, 2026. The portfolio has not yet recovered.

The current 22526-2 drawdown is 7.68%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-13.09%Mar 2, 202615Mar 20, 2026
-11.87%Apr 3, 20254Apr 8, 202528May 19, 202532
-9.13%Oct 23, 202441Dec 19, 202436Feb 13, 202577
-6.91%Jan 29, 20266Feb 5, 202614Feb 26, 202620
-6.53%Jul 17, 202416Aug 7, 20248Aug 19, 202424

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 23 assets, with an effective number of assets of 3.29, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkENVBOUNZALKSSIVRDFTXMSTYCMPSGDXPPHVYGRMRNYMLIRAAXRDIVICLNSCHGFRNWPBEFMEDPBDIBBQVOOVXUSPortfolio
Benchmark1.000.210.110.280.220.340.430.340.240.370.400.370.550.380.500.480.940.530.550.640.610.551.000.720.52
ENVB0.211.000.010.140.070.190.130.140.080.160.210.240.190.130.220.170.180.210.250.300.220.240.210.190.21
OUNZ0.110.011.000.020.750.070.120.090.800.120.100.120.080.670.040.230.080.210.130.120.240.160.110.350.66
ALKS0.280.140.021.000.050.200.160.200.070.340.350.300.280.130.330.210.200.210.490.400.260.500.280.260.24
SIVR0.220.070.750.051.000.100.180.150.770.110.110.180.110.560.090.270.200.270.170.170.330.200.220.440.70
DFTX0.340.190.070.200.101.000.300.480.100.180.380.220.260.230.220.260.330.280.400.380.290.440.340.300.23
MSTY0.430.130.120.160.180.301.000.270.190.060.300.220.290.240.240.300.460.360.290.330.420.310.430.360.29
CMPS0.340.140.090.200.150.480.271.000.120.200.430.310.190.180.210.250.330.300.380.420.350.490.340.330.23
GDX0.240.080.800.070.770.100.190.121.000.180.120.160.170.610.120.340.200.330.210.220.340.240.250.470.82
PPH0.370.160.120.340.110.180.060.200.181.000.300.340.260.200.400.240.220.250.600.530.280.650.370.450.39
VYGR0.400.210.100.350.110.380.300.430.120.301.000.400.300.160.320.260.360.320.490.480.370.580.400.370.29
MRNY0.370.240.120.300.180.220.220.310.160.340.401.000.320.220.330.330.300.350.500.490.440.580.370.410.34
MLI0.550.190.080.280.110.260.290.190.170.260.300.321.000.370.550.310.440.360.440.440.430.390.550.470.45
RAAX0.380.130.670.130.560.230.240.180.610.200.160.220.371.000.410.390.260.410.280.270.430.300.380.510.75
RDIV0.500.220.040.330.090.220.240.210.120.400.320.330.550.411.000.350.280.390.510.440.450.480.500.490.59
ICLN0.480.170.230.210.270.260.300.250.340.240.260.330.310.390.351.000.410.930.370.370.810.420.480.630.47
SCHG0.940.180.080.200.200.330.460.330.200.220.360.300.440.260.280.411.000.470.450.580.550.460.940.620.38
FRNW0.530.210.210.210.270.280.360.300.330.250.320.350.360.410.390.930.471.000.390.430.870.440.530.660.49
PBE0.550.250.130.490.170.400.290.380.210.600.490.500.440.280.510.370.450.391.000.750.460.880.550.520.47
FMED0.640.300.120.400.170.380.330.420.220.530.480.490.440.270.440.370.580.430.751.000.510.780.640.570.45
PBD0.610.220.240.260.330.290.420.350.340.280.370.440.430.430.450.810.550.870.460.511.000.510.620.770.54
IBBQ0.550.240.160.500.200.440.310.490.240.650.580.580.390.300.480.420.460.440.880.780.511.000.560.550.48
VOO1.000.210.110.280.220.340.430.340.250.370.400.370.550.380.500.480.940.530.550.640.620.561.000.730.52
VXUS0.720.190.350.260.440.300.360.330.470.450.370.410.470.510.490.630.620.660.520.570.770.550.731.000.67
Portfolio0.520.210.660.240.700.230.290.230.820.390.290.340.450.750.590.470.380.490.470.450.540.480.520.671.00
The correlation results are calculated based on daily price changes starting from Feb 23, 2024